CASI Pharmaceuticals, Inc. (29) | Stock Agreements (3)
- Description of Common Stock (Filed With SEC on March 30, 2021)
- Description of Common Stock (Filed With SEC on March 16, 2020)
- Amendment No. 1 to Common Stock Sales Agreement by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated July 19, 2019 (Filed With SEC on July 19, 2019)
